share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Gallman Cari

SEC announcement ·  Mar 12 20:04
Summary by Moomoo AI
On March 10, 2024, Cari Gallman, EVP of Corporate Affairs at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Gallman acquired a total of 2,761 shares through the exercise or conversion of derivative securities at no cost. On the same day, Gallman disposed of 1,535 shares. The disposals included shares used to cover exercise prices or tax liabilities, with some transactions priced at $53.79 per share, totaling a market value of $37,437.84. Following these transactions, Gallman's direct holdings in Bristol-Myers Squibb common stock amounted to 1,432 shares.
On March 10, 2024, Cari Gallman, EVP of Corporate Affairs at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Gallman acquired a total of 2,761 shares through the exercise or conversion of derivative securities at no cost. On the same day, Gallman disposed of 1,535 shares. The disposals included shares used to cover exercise prices or tax liabilities, with some transactions priced at $53.79 per share, totaling a market value of $37,437.84. Following these transactions, Gallman's direct holdings in Bristol-Myers Squibb common stock amounted to 1,432 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more